Matthew Marano, MD
Ophthalmology · Livingston, NJNPI 1639112097
Payments from drug & device makers
Across 753 payments — averaging $52.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$24K
- Sight Sciences, Inc.$5K
- Alcon$3K
- Bausch & Lomb Americas Inc.$2K
- Glaukos Corporation$987
- Sun Pharmaceutical Industries Inc.$593
- plus $4K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 218 | $23,563 |
| Sight Sciences, Inc. | 107 | $5,230 |
| Alcon | 86 | $3,256 |
| Bausch & Lomb Americas Inc. | 107 | $1,806 |
| Glaukos Corporation | 11 | $987 |
| Sun Pharmaceutical Industries Inc. | 28 | $593 |
| Amgen(2 entities) | 9 | $579 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $427 |
| Novartis | 51 | $419 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 45 | $394 |
| Ocular Therapeutix, Inc. | 18 | $268 |
| Oyster Point Pharma, Inc. | 13 | $226 |
| Harrow Eye, LLC | 7 | $221 |
| Biotissue Holdings Inc. | 11 | $204 |
| Mallinckrodt Hospital Products Inc. | 4 | $178 |
| Rxsight Inc | 1 | $147 |
| Iridex Corporation | 1 | $133 |
| Aerie Pharmaceuticals, Inc. | 8 | $114 |
| Kala Pharmaceuticals, Inc. | 6 | $107 |
| Tarsus Pharmaceuticals, Inc. | 5 | $94 |
| Carl Zeiss Meditec, Inc. | 1 | $67 |
| Omeros Corporation | 2 | $38 |
| Eyevance Pharmaceuticals LLC | 2 | $32 |
| Shire North American Group Inc | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Travere Therapeutics, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Rayner Intraocular Lenses Limited | 1 | $14 |
How this compares
$39,191 in reported general payments places this provider in the 90th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Livingston
- Patrick HigginsBloomfield$16.7M
- Jai ParekhWoodland Park$2.1M
- Eric MannDover$860K
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Luis Gonzalez GonzalezTeaneck$727K
- Cynthia MatossianPennington$726K
- Charles CraneSouth Orange$582K
- Albert KhouriNewark$542K
- Brett BieloryRutherford$477K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.